Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
McGill University |
---|---|
Information provided by: | McGill University |
ClinicalTrials.gov Identifier: | NCT00818285 |
Drug-related illness accounts for 5% to 23% of hospital admissions, and is now claimed to be the sixth leading cause of mortality. Older adults are at higher risk of adverse drug-related events, and medication-related fall injuries are the most common adverse event that could be potentially prevented. There are 1.2 million falls per year among Canadian elderly, at a cost of $2.4 billion in health care services, and substantial risk of loss of independence.
The overall purpose of this research program is to reduce medication-related fall injuries by using computerized electronic prescribing and drug management systems to identify high risk patients and provide physicians with patient-specific recommendations for modifying psychotropic medication use to reduce this risk.
Condition | Intervention |
---|---|
Fall Related Injuries |
Device: CDS for psychotropic drug management |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment |
Official Title: | Reducing Injuries From Medication-Related Falls by Generating Targeted Computerized Alerts for High Risk Patients Within an Electronic Prescribing System |
Estimated Enrollment: | 4800 |
Study Start Date: | September 2008 |
Estimated Study Completion Date: | December 2008 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: No Intervention
Physicians in this arm will be using the standard electronic prescription interface.
|
|
2: Experimental
In addition to the standard electronic prescription module, physicians in this arm will receive targeted drugs alert and decision support for psychotropic drug management
|
Device: CDS for psychotropic drug management
Computerized decision support (CDS) for patients with available supplies of psychotropic medications. The decision support will consist of a screen displaying to the physician the patient's current risk of falling as well as what their risk could be lowered to with modifications to medications.
|
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Robyn Tamblyn, PhD | 514-934-1934 ext 32999 | robyn.tamblyn@mcgill.ca |
Canada, Quebec | |
McGill University | Recruiting |
Montreal, Quebec, Canada | |
Contact: Robyn Tamblyn, PhD 514-934-1934 ext 32999 robyn.tamblyn@mcgill.ca |
Principal Investigator: | Robyn M Tamblyn, PhD | McGill University |
Responsible Party: | McGill University ( Dr Robyn Tamblyn ) |
Study ID Numbers: | RFA06-1035-QC |
Study First Received: | January 5, 2009 |
Last Updated: | January 5, 2009 |
ClinicalTrials.gov Identifier: | NCT00818285 |
Health Authority: | Canada: Ethics Review Committee |